Related Experiment Videos
Tyrosine phosphate in melanoma progression
L McArdle1, O Bergin, M E Fallowfield
1Department of Pathology, Conway Institute, University College Dublin, Dublin 4, Ireland.
The British Journal of Dermatology
|August 23, 2003
Summary
Increased phosphotyrosine signaling and protein tyrosine phosphatase (PTP) activity correlate with melanoma progression. These changes are particularly evident in advanced melanoma stages, suggesting a role in metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Cellular tyrosine phosphorylation is regulated by protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs).
- PTKs are implicated in oncogenesis, while PTPs are hypothesized to act as tumor suppressors.
- Understanding these enzyme families is crucial for cancer research.
Purpose of the Study:
- To investigate alterations in phosphotyrosine levels and PTP activity during melanoma development.
- To correlate these molecular changes with melanoma progression and metastatic potential.
Main Methods:
- Immunohistochemistry was employed to detect phosphotyrosine in various melanocytic lesions.
- Enzyme-linked immunosorbent assay (ELISA) was used to measure PTP activity in normal melanocytes and melanoma cell lines.
Main Results:
- Phosphotyrosine immunostaining was minimal in normal skin, benign nevi, and early-stage melanomas.
- Advanced melanoma stages (vertical growth phase and metastatic) showed significant phosphotyrosine immunoreactivity.
- A notable increase in total PTP enzyme activity was observed in melanoma cell lines compared to normal melanocytes.
Conclusions:
- Increased phosphotyrosine signaling is associated with melanoma progression.
- Elevated PTP activity accompanies melanoma advancement.
- These molecular changes appear during the stage of melanoma when cells gain metastatic competence.